Skip to content

A Prospective Clinical Study on MRI-based Automated Measurement of Curved Tumor-Anal Verge Distance in Rectal Cancer

A Prospective Clinical Study on MRI-based Automated Measurement of Curved Tumor-Anal Verge Distance in Rectal Cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600126849
Enrollment
Unknown
Registered
2026-06-17
Start date
2026-06-20
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rectal cancer

Interventions

Observation group:None

Sponsors

Shanghai General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Patients with a confirmed diagnosis of rectal cancer established via clinical examination and/or pathological assessment. 2.Patients receiving treatment at the study center during the study period, who have completed or are scheduled to complete routine preoperative magnetic resonance imaging (MRI) for rectal cancer. 3.MRI image quality meets the requirements for imaging analysis and measurement, clearly visualizing the rectum and tumor-related anatomical structures. 4.Age >= 18 years, regardless of gender. 5.Capable of understanding the study content and voluntarily signing the informed consent form based on full information.

Exclusion criteria

Exclusion criteria: 1.Prior surgical history affecting anatomy:Patients who have undergone previous surgeries that may significantly alter the anatomical structure of the rectum or anal canal (e.g., low anterior resection, abdominoperineal resection), thereby affecting the accurate assessment of the tumor-anal verge distance. 2.Incomplete or poor-quality imaging: Patients with incomplete preoperative magnetic resonance imaging (MRI) data or poor image quality that fails to meet the requirements for imaging analysis and measurement. Confounding comorbidities:; 3.Presence of severe rectal or pelvic comorbidities (e.g., severe inflammation, malformations) that interfere with image interpretation or measurement. 4.Inability to comply or other disqualifiers: Patients unable to cooperate with the collection of study-related information, or other conditions deemed by the investigator as unsuitable for inclusion in this study.

Design outcomes

Primary

MeasureTime frame
Magnetic Resonance Imaging of the Pelvis;Postoperative pathology;3D curved-path MRI-measured DTAV;

Countries

China

Contacts

Public ContactHuang Chen

Shanghai General Hospital

richard-hc@hotmail.com+86 13381758371

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 29, 2026